Brook I, Foote P A
Department of Pediatrics, Georgetown University School of Medicine, Washington, DC, USA.
J Antimicrob Chemother. 1997 Nov;40(5):725-8. doi: 10.1093/jac/40.5.725.
The effect on the tonsillar bacterial flora of antimicrobial therapy with penicillin or a second-generation cephalosporin (cefprozil) was studied. Sixty children scheduled for elective tonsillectomy because of recurrent group A beta-haemolytic streptococcal tonsillitis participated in a prospective randomized study that divided them into three groups. One group received no therapy, and the others were given either penicillin or cefprozil for 10 days prior to surgery. The core of the patients' tonsils was cultured for aerobic bacteria. Group A beta-haemolytic streptococci (GABHS) were isolated from 15/20 (75%) of untreated, 11/20 (55%) of penicillin, and 2/20 (10%) of the cefprozil group (P < 0.001). Thirty-two beta-lactamase-producing bacteria were recovered from 19/20 (95%) of untreated, 33 from 17/20 (85%) treated with penicillin and six from 4/20 (20%) treated with cefprozil (P < 0.01). Alpha-haemolytic streptococci (AHS) inhibiting GABHS were less often isolated from patients treated with penicillin. These data illustrate the ability of a second-generation cephalosporin to eradicate GABHs, as well as beta-lactamase-producing bacteria, while preserving AHS.
研究了青霉素或第二代头孢菌素(头孢丙烯)抗菌治疗对扁桃体细菌菌群的影响。60名因复发性A组β溶血性链球菌扁桃体炎而计划接受择期扁桃体切除术的儿童参与了一项前瞻性随机研究,该研究将他们分为三组。一组未接受治疗,其他两组在手术前10天分别给予青霉素或头孢丙烯治疗。对患者扁桃体核心部位进行需氧菌培养。未治疗组20例中有15例(75%)分离出A组β溶血性链球菌(GABHS),青霉素治疗组20例中有11例(55%),头孢丙烯治疗组20例中有2例(10%)(P<0.001)。未治疗组20例中有19例(95%)分离出32株产β-内酰胺酶细菌,青霉素治疗组20例中有17例(85%)分离出33株,头孢丙烯治疗组20例中有4例(20%)分离出6株(P<0.01)。抑制GABHS的α溶血性链球菌(AHS)在青霉素治疗患者中分离较少。这些数据表明第二代头孢菌素能够根除GABHS以及产β-内酰胺酶细菌,同时保留AHS。